Rapid Communication - Gynecology and Reproductive Endocrinology (2025) Volume 9, Issue 1
In Vitro Fertilization (IVF): A Breakthrough in Reproductive Medicine
Vigna Michel *
Department of Biomedical Sciences, University of Milan, Italy
- *Corresponding Author:
- Vigna Michel
Department of Biomedical Sciences, University of Milan, Italy
E-mail: michel@unimi.it
Received: 01-Jan-2025, Manuscript No. AAGGS-25-164196; Editor assigned: 02-Jan-2025, Pre QC No. AAGGS-25-164196(PQ); Reviewed:15-Jan-2025, QC No. AAGGS-25-164196; Revised: 20-Jan-2025, Manuscript No. AAGGS-25-164196(R), Published: 27-Jan-2025,DOI:10.35841/aaggs-9.1.246
Citation: Michel V. Balancing hormones: In Vitro fertilization (IVF): A breakthrough in reproductive medicine. Allied J Med Res. 2024;9(1):246
Introduction
In Vitro Fertilization (IVF) has revolutionized reproductive medicine, offering hope to millions of individuals and couples facing infertility. Since the birth of the first “test-tube baby” in 1978, IVF has evolved significantly in terms of safety, efficiency, and accessibility. As infertility affects approximately 10-15% of couples worldwide, IVF remains a cornerstone in assisted reproductive technologies (ART), bridging the gap between hope and parenthood.[1,2].
IVF involves a multi-step process that begins with ovarian stimulation, where hormonal medications are used to encourage the development of multiple eggs. Once the follicles reach maturity, eggs are retrieved from the ovaries through a minor surgical procedure. These eggs are then fertilized with sperm in a controlled laboratory environment, hence the term “in vitro,” meaning “in glass.” Successful fertilization results in embryo formation, which can then be transferred to the uterus for potential implantation. [3,4].
One of the most significant advancements in IVF is the development of embryo freezing and vitrification techniques. This allows patients to preserve unused embryos for future attempts, reducing the physical and financial strain of undergoing repeated full IVF cycles. Additionally, preimplantation genetic testing (PGT) can be performed to screen embryos for genetic abnormalities, increasing the chances of a successful pregnancy and reducing the risk of inherited diseases. IVF has also extended its reach beyond traditional infertility cases. It has become an important option for single individuals, same-sex couples, and people seeking fertility preservation before undergoing medical treatments that may affect reproductive function, such as chemotherapy. Thus, IVF continues to serve a diverse and growing population with various reproductive needs [5,6].
Despite its success, IVF is not without challenges. The procedure can be emotionally and physically demanding, often requiring multiple cycles for success. Moreover, the cost of IVF remains high in many countries, making it inaccessible to some patients. Ethical debates surrounding the manipulation of embryos and the fate of unused embryos also continue to spark discussions in both medical and public domains. [7,8].
The success rates of IVF vary depending on several factors, including maternal age, the cause of infertility, and the quality of the embryos. Younger women tend to have higher success rates, while women over 40 may face significantly lower chances. Nevertheless, IVF offers many hopeful couples a viable path to parenthood, particularly when other treatments have failed. The success rates of IVF vary depending on several factors, including maternal age, the cause of infertility, and the quality of the embryos. Younger women tend to have higher success rates, while women over 40 may face significantly lower chances. Nevertheless, IVF offers many hopeful couples a viable path to parenthood, particularly when other treatments have failed [9,10].
Conclusion
As the field of reproductive medicine progresses, IVF remains a beacon of scientific and emotional hope. With ongoing research, improved accessibility, and societal acceptance, the future of IVF holds promise for even greater success and inclusivity in helping people achieve their dreams of becoming parents.
References
- Deputy NP, Sharma AJ, Kim SY, et al. Prevalence and characteristics associated with gestational weight gain adequacy. Obstetr and Gynec. 2015;125(4):773.
- Goldstein RF, Abell SK, Ranasinha S, et al. Association of gestational weight gain with maternal and infant outcomes: a systematic review and meta-analysis. JAMA. 2017;317(21):2207-25.
- Ferrari RM, Siega-Riz AM. Provider advice about pregnancy weight gain and adequacy of weight gain.Maternal and Child Health J. 2013;17(2):256-64.
- Stotland N, Tsoh JY, Gerbert B. Prenatal weight gain: who is counseled?. J Women's Health. 2012;21(6):695-701.
- Bieler GS, Brown GG, Williams RL, et al. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am J Epidemiol. 2010;171(5):618-23.
- Johnson NP, Hummelshoj L, Abrao MS, et al. Consensus on current management of endometriosis. Human Reprod. 2013;28(6):1552-68.
- Whitaker LH, Reid J, Choa A, et al. An exploratory study into objective and reported characteristics of neuropathic pain in women with chronic pelvic pain. PLoS One. 2016;11(4):e0151950.
- Mowers EL, Lim CS, Skinner B, et al. Prevalence of endometriosis during abdominal or laparoscopic hysterectomy for chronic pelvic pain. Obstetr & Gynec. 2016;127(6):1045-53.
- Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis. Endocr Rev. 2019;40:1048-79.
- Leyland N, Casper R, Laberge P, et al. Endometriosis: Diagnosis and management. J Endometr. 2010;2(3):107-34
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref
Indexed at, Google Scholar, Cross Ref